AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
-0.94%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$4.22B
AUM Growth
+$4.22B
(-14%)
Cap. Flow
-$4.61M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
84.43%
Holding
46
New
10
Increased
–
Reduced
6
Closed
3
Top Buys
| 1 |
Robinhood
HOOD
|
$324M |
| 2 |
Invivyd
IVVD
|
$240M |
| 3 |
Duolingo
DUOL
|
$118M |
| 4 |
BHIL
Benson Hill, Inc.
BHIL
|
$105M |
| 5 |
Illumina
ILMN
|
$21.7M |
Top Sells
| 1 |
UiPath
PATH
|
$602M |
| 2 |
Airbnb
ABNB
|
$80.5M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
$57.6M |
| 4 |
Clover Health Investments
CLOV
|
$54.8M |
| 5 |
Beam Therapeutics
BEAM
|
$27.3M |
Sector Composition
| 1 | Healthcare | 54.75% |
| 2 | Technology | 32.88% |
| 3 | Financials | 7.69% |
| 4 | Consumer Staples | 2.5% |
| 5 | Industrials | 1.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$5.95B
| $925M | 21.94% | 17,581,428 -11,444,357 | -39% | -$602M |
|
|
VERV
2
DELISTED
Verve Therapeutics
VERV
| $516M | 12.24% | 10,974,011 | – | – |
|
3
DexCom
DXCM
$29.5B
| $440M | 10.45% | 805,681 | – | – |
|
4
Oscar Health
OSCR
$4.31B
| $418M | 9.92% | 24,042,864 | – | – |
|
5
Lyft
LYFT
$6.73B
| $329M | 7.8% | 6,138,154 | – | – |
|
|
6
Robinhood
HOOD
$92.4B
| $324M | 7.68% | +7,697,335 | New | +$324M |
|
|
7
Invivyd
IVVD
$204M
| $240M | 5.69% | +5,680,785 | New | +$240M |
|
8
Arcus Biosciences
RCUS
$1.13B
| $143M | 3.39% | 4,100,475 -513,343 | -11% | -$17.9M |
|
|
9
Duolingo
DUOL
$13.6B
| $118M | 2.81% | +712,304 | New | +$118M |
|
|
BHIL
10
DELISTED
Benson Hill, Inc.
BHIL
| $105M | 2.5% | +14,752,271 | New | +$105M |
|
11
Lyell Immunopharma
LYEL
$213M
| $86.8M | 2.06% | 5,865,125 | – | – |
|
|
DM
12
DELISTED
Desktop Metal, Inc.
DM
| $79.2M | 1.88% | 11,048,730 | – | – |
|
13
Sana Biotechnology
SANA
$777M
| $63.3M | 1.5% | 2,812,500 | – | – |
|
14
Relay Therapeutics
RLAY
$619M
| $51.8M | 1.23% | 1,641,497 -185,379 | -10% | -$5.84M |
|
15
Monte Rosa Therapeutics
GLUE
$296M
| $32.6M | 0.77% | 1,464,015 | – | – |
|
|
KRON
16
DELISTED
Kronos Bio
KRON
| $30.1M | 0.72% | 1,438,232 | – | – |
|
|
17
Beam Therapeutics
BEAM
$1.66B
| $28M | 0.66% | 321,604 -313,982 | -49% | -$27.3M |
|
|
BRNS
18
Barinthus Biotherapeutics
BRNS
$45.6M
| $26.8M | 0.64% | 1,704,444 | – | – |
|
19
Dianthus Therapeutics
DNTH
$759M
| $24.3M | 0.58% | 3,339,138 | – | – |
|
20
RAPT Therapeutics
RAPT
$188M
| $22.1M | 0.52% | 710,250 -78,563 | -10% | -$2.44M |
|
|
21
Illumina
ILMN
$15.8B
| $21.7M | 0.51% | +53,470 | New | +$21.7M |
|
22
IDEAYA Biosciences
IDYA
$2.15B
| $19.2M | 0.46% | 753,187 | – | – |
|
23
Tenaya Therapeutics
TNYA
$184M
| $18.9M | 0.45% | +915,705 | New | +$18.9M |
|
24
Quince Therapeutics
QNCX
$85.9M
| $17.3M | 0.41% | 189,122 | – | – |
|
25
Vera Therapeutics
VERA
$1.38B
| $16.4M | 0.39% | 944,791 | – | – |
|